reglab/housing_qa huggingface dataset:
NM Stat § 26-1-25 (2021)
2021 New Mexico Statutes|Chapter 26 - Drugs and Cosmetics|Article 1 - General Provisions|Section 26-1-25 - Cosmetics; adulteration.

A cosmetic shall be deemed to be adulterated: A. if it bears or contains any poisonous or deleterious substance which may render it injurious to users under the conditions of use prescribed in the labeling or advertisements thereof, or under such conditions of use as are customary or usual; provided, that this provision shall not apply to coal-tar dye, the label of which bears the following legend conspicuously displayed thereon: "CAUTION: This product contains ingredients which may cause skin irritations on certain individuals and a preliminary test according to accompanying directions should first be made. This product must not be used for dyeing the eyelashes or eyebrows; to do so may cause blindness," and the labeling of which bears adequate directions for such preliminary testing. For the purpose of this paragraph and Subsection E the term "hair dye" shall not include eyelash dyes or eyebrow dyes; B. if it consists in whole or in part of any filthy, putrid or decomposed substance; C. if it has been produced, prepared, packed or held under unsanitary conditions whereby it may have become contaminated with filth, or whereby it may have been rendered injurious to health; D. if its container is composed, in whole or in part, of any poisonous or deleterious substance which may render the contents injurious to health; or E. if it is not a hair dye, and it bears or contains a color additive which is unsafe within the meaning of the federal act. History: 1953 Comp., § 54-6-50, enacted by Laws 1967, ch. 23, § 25. ANNOTATIONSCross references. — For definition of "contaminated with filth", see 26-1-2 NMSA 1978. For definition of "color additive", see 26-1-2 NMSA 1978. For definition of "federal act", see 26-1-2 NSMA 1978 and notes thereto. Am. Jur. 2d, A.L.R. and C.J.S. references. — Products liability: perfumes, colognes, or deodorants, 46 A.L.R.4th 1197. 2 C.J.S. Adulteration § 2.
NM Stat § 26-1-26 (2021)
2021 New Mexico Statutes|Chapter 26 - Drugs and Cosmetics|Article 1 - General Provisions|Section 26-1-26 - Penalties.

A. Any person who knowingly violates any of the provisions of Subsection A, B, C, F, G or H of Section 26-1-3, Section 26-1-14, 26-1-16, 26-1-22 or 26-1-23 NMSA 1978 is guilty of a fourth degree felony and shall be punished by a fine of not less than one thousand dollars ($1,000) or more than five thousand dollars ($5,000) or by imprisonment for not less than one year or both. B. Except as provided in Subsection A of this section, any person violating any of the provisions of the New Mexico Drug, Device and Cosmetic Act is guilty of a misdemeanor for the first offense and for second and subsequent offenses is guilty of a fourth degree felony. History: 1953 Comp., § 54-6-51, enacted by Laws 1967, ch. 23, § 26; 1971, ch. 245, § 4; 1972, ch. 84, § 53; 1987, ch. 270, § 7. ANNOTATIONSThe 1987 amendment, effective June 19, 1987, in Subsection A, updated the statutory references, deleted "a misdemeanor and shall be punished by a fine of not more than one thousand dollars ($1,000) or by imprisonment for not more than one year for the first offense and for second and subsequent offenses is guilty of" following "is guilty of," and added the language at the end of the subsection following "fourth degree felony"; and, in Subsection B, inserted "Device," deleted "petty" preceding "misdemeanor," and made a minor stylistic change. Methaqualone. — The legislature has not specifically designated methaqualone as a "controlled substance" or "dangerous drug" under either the Controlled Substances Act or this article, but has authorized the board of pharmacy to add this substance by administrative regulation to the list of substances controlled under these acts. State v. Reams, 1981-NMCA-158, 98 N.M. 372, 648 P.2d 1185, aff'd in part, rev'd in part, 1982-NMSC-075, 98 N.M. 215, 647 P.2d 417.
NM Stat § 26-2-1 to 26-2-4 (2021)
2021 New Mexico Statutes|Chapter 26 - Drugs and Cosmetics|Article 2 - Drug Abuse (Repealed, Recompiled.)|Section 26-2-1 to 26-2-4 - Repealed.

ANNOTATIONSRepeals. — Laws 1999, ch. 270, § 10 repealed 26-2-1 to 26-2-4 NMSA 1978, as enacted by Laws 1971, ch. 244, §§ 1 to 3 and as amended by Laws 1987, ch. 265, § 4, relating to the Drug Abuse Act, effective July 1, 1999. For provisions of former sections, see the 1998 NMSA 1978 on NMOneSource.com. For present comparable provisions, see 9-7-6.1 to 9-7-6.3 NMSA 1978.
NM Stat § 26-2-4.1 (2021)
2021 New Mexico Statutes|Chapter 26 - Drugs and Cosmetics|Article 2 - Drug Abuse (Repealed, Recompiled.)|Section 26-2-4.1 - Recompiled.

ANNOTATIONSRecompilations. — Laws 1999, ch. 270, § 9 recompiled 26-2-4.1 NMSA 1978, relating to the substance abuse education fund, as 9-7-17 NMSA 1978, effective July 1, 1999.
NM Stat § 26-2-5 to 26-2-14 (2021)
2021 New Mexico Statutes|Chapter 26 - Drugs and Cosmetics|Article 2 - Drug Abuse (Repealed, Recompiled.)|Section 26-2-5 to 26-2-14 - Repealed.

ANNOTATIONSRepeals. — Laws 1999, ch. 270, § 10 repealed 26-2-5 to 26-2-14 NMSA 1978, as enacted by Laws 1971, ch. 244, §§ 5 to 12, Laws 1971, ch. 296, § 1 and Laws 1972, ch. 10, § 1, and as amended by Laws 1972, ch. 84, § 54, relating to drug abuse services, effective July 1, 1999. For provisions of former sections, see the 1998 NMSA 1978 on NMOneSource.com. For present comparable provisions, see 9-7-6.1 to 9-7-6.3 NMSA 1978.
NM Stat § 26-2A-1 (2021)
2021 New Mexico Statutes|Chapter 26 - Drugs and Cosmetics|Article 2A - Controlled Substances Therapeutic Research|Section 26-2A-1 - Short title.

Sections 1 through 7 [26-2A-1 to 26-2A-7 NMSA 1978] of this act may be cited as the "Controlled Substances Therapeutic Research Act". History: 1953 Comp., § 54-15-1, enacted by Laws 1978, ch. 22, § 1.
NM Stat § 26-2A-2 (2021)
2021 New Mexico Statutes|Chapter 26 - Drugs and Cosmetics|Article 2A - Controlled Substances Therapeutic Research|Section 26-2A-2 - Purpose.

The legislature finds that recent research has shown that the use of marijuana may alleviate the nausea and ill-effects of cancer chemotherapy, and, additionally, may alleviate the ill-effects of glaucoma. The legislature further finds that there is a need for further research and experimentation with regards to the use of marijuana under strictly controlled circumstances. It is for this purpose that the Controlled Substances Therapeutic Research Act is hereby enacted. History: 1953 Comp., § 54-12-2, enacted by Laws 1978, ch. 22, § 2.
NM Stat § 26-2A-3 (2021)
2021 New Mexico Statutes|Chapter 26 - Drugs and Cosmetics|Article 2A - Controlled Substances Therapeutic Research|Section 26-2A-3 - Definitions.

As used in the Controlled Substances Therapeutic Research Act: A. "administrator" means the secretary, or his designee, of health and environment; B. "marijuana" means marijuana, tetrahydrocannabinols or a chemical derivative of tetrahydrocannabinol; and C. "practitioner" means a physician licensed to prescribe and administer drugs which are subject to the Controlled Substances Act [Chapter 30, Article 31 NMSA 1978]. History: 1953 Comp., § 54-12-3, enacted by Laws 1978, ch. 22, § 3. ANNOTATIONSCompiler's notes. — Laws 1991, ch. 25, § 16 repealed former 9-7-4 NMSA 1978, relating to the health and environment department, and enacted a new 9-7-4 NMSA 1978, creating the department of health. Laws 1991, ch. 25, § 4 created the department of environment. Under 9-7-5 NMSA 1978, the administrative head of the department of health is the secretary of health. Under 9-7A-5 NMSA 1978, the administrative head of the department of environment is the secretary of environment.
NM Stat § 26-2A-4 (2021)
2021 New Mexico Statutes|Chapter 26 - Drugs and Cosmetics|Article 2A - Controlled Substances Therapeutic Research|Section 26-2A-4 - Lynn Pierson therapeutic research program established; participation.

A. There is established in the health and environment department [department of health] the "Lynn Pierson therapeutic research program". The program shall be administered by the administrator. The department shall promulgate rules and regulations necessary for the proper administration of the Controlled Substances Therapeutic Research Act. In such promulgation, the department shall take into consideration those pertinent rules and regulations promulgated by the drug enforcement administration, food and drug administration and the national institute on drug abuse. B. Except as provided in Subsection C of Section 5 [26-2A-5 NMSA 1978] of the Controlled Substances Therapeutic Research Act, the Lynn Pierson therapeutic research program shall be limited to cancer chemotherapy patients and glaucoma patients, who are certified to the patient qualification review board by a physician as being involved in a life-threatening or sense-threatening situation and who are not responding to conventional controlled substances or where the conventional controlled substances administered have proven to be effective but where the patient has incurred severe side effects. History: 1953 Comp., § 54-12-4, enacted by Laws 1978, ch. 22, § 4; 1979, ch. 11, § 1. ANNOTATIONSBracketed material. — The bracketed material was inserted by the compiler and is not part of the law. Laws 1991, ch. 25, § 16 repealed former 9-7-4 MNSA 1978, relating to the health and environment department, and enacted a new 9-7-4 NMSA 1978, creating the department of health.
NM Stat § 26-2A-5 (2021)
2021 New Mexico Statutes|Chapter 26 - Drugs and Cosmetics|Article 2A - Controlled Substances Therapeutic Research|Section 26-2A-5 - Patient qualification review board; composition; powers and duties.

A. The administrator, upon the recommendation of the New Mexico medical society, shall appoint a patient qualification review board to serve at his pleasure. The patient qualification review board shall be comprised of: (1) a physician licensed to practice medicine in New Mexico and certified by the American board of ophthalmology; (2) a physician licensed to practice medicine in New Mexico and certified by the American board of internal medicine and also certified in the subspecialty of medical oncology; and (3) a physician licensed to practice medicine in New Mexico and certified in psychiatry by the American board of psychiatry and neurology. Members of the board may be reimbursed for their attendance at meetings at the rate of forty dollars ($40.00) per day. B. The patient qualification review board shall review all applicants for the Lynn Pierson therapeutic research program and their licensed physicians and certify their participation in the program. C. The patient qualification review board may include other disease groups for participation in the Lynn Pierson therapeutic research program after pertinent medical data have been presented by a physician to both the administrator and the board and after receiving the necessary approval of the food and drug administration, the drug enforcement administration and the national institute on drug abuse. History: 1953 Comp., § 54-12-5, enacted by Laws 1978, ch. 22, § 5; 1979, ch. 11, § 2.
NM Stat § 26-2A-6 (2021)
2021 New Mexico Statutes|Chapter 26 - Drugs and Cosmetics|Article 2A - Controlled Substances Therapeutic Research|Section 26-2A-6 - Lynn Pierson therapeutic research program; distribution.

A. The administrator shall obtain marijuana through whatever means he deems most appropriate, consistent with regulations promulgated by the national institute on drug abuse, the food and drug administration and the drug enforcement administration and pursuant to the provisions of the Controlled Substances Therapeutic Research Act. B. The administrator shall cause such marijuana to be transferred to a certified state-operated licensed pharmacy for distribution to the certified patient pursuant to the Controlled Substances Therapeutic Research Act. History: 1953 Comp., § 54-12-6, enacted by Laws 1978, ch. 22, § 6; 1979, ch. 11, § 3.
NM Stat § 26-2A-7 (2021)
2021 New Mexico Statutes|Chapter 26 - Drugs and Cosmetics|Article 2A - Controlled Substances Therapeutic Research|Section 26-2A-7 - Report.

The administrator, in conjunction with the patient qualification review board, shall each year report his findings and recommendations to the governor and the legislature regarding the effectiveness of the Lynn Pierson therapeutic research program. History: 1953 Comp., § 54-12-7, enacted by Laws 1978, ch. 22, § 7; 1979, ch. 11, § 4. ANNOTATIONSCompiler's notes. — Laws 1979, ch. 11, § 5, effective March 7, 1979, repealed Laws 1978, ch. 22, § 10, which would have repealed the Controlled Substances Therapeutic Research Act (26-2A-1 to 26-2A-7 NMSA 1978) effective July 1, 1979.
NM Stat § 26-2B-1 (2021)
2021 New Mexico Statutes|Chapter 26 - Drugs and Cosmetics|Article 2B - Lynn and Erin Compassionate Use Act|Section 26-2B-1 - Short title.

Chapter 26, Article 2B NMSA 1978 may be cited as the "Lynn and Erin Compassionate Use Act" in honor of Lynn Pierson and Erin Armstrong. History: Laws 2007, ch. 210, § 1; 2019, ch. 247, § 2. ANNOTATIONSSeverability. — Laws 2007, ch. 210, §11 provided for the severability of the Lynn and Erin Compassionate Use Act if any part or application thereof is held invalid. The 2019 amendment, effective June 14, 2019, changed "Sections 1 through 7 of this act" to "Chapter 26, Article 2B NMSA 1978".
NM Stat § 26-2B-2 (2021)
2021 New Mexico Statutes|Chapter 26 - Drugs and Cosmetics|Article 2B - Lynn and Erin Compassionate Use Act|Section 26-2B-2 - Purpose of act.

The purpose of the Lynn and Erin Compassionate Use Act is to allow the beneficial use of medical cannabis in a regulated system for alleviating symptoms caused by debilitating medical conditions and their medical treatments. History: Laws 2007, ch. 210, § 2. ANNOTATIONSEffective dates. — Laws 2007, ch. 210, § 12 made the Lynn and Erin Compassionate Use Act effective July 1, 2007. Severability. — Laws 2007, ch. 210, §11 provided for the severability of the Lynn and Erin Compassionate Use Act if any part or application thereof is held invalid.
NM Stat § 26-2B-5 (2021)
2021 New Mexico Statutes|Chapter 26 - Drugs and Cosmetics|Article 2B - Lynn and Erin Compassionate Use Act|Section 26-2B-5 - Prohibitions, restrictions and limitations on the medical use of cannabis; criminal penalties.

A. Participation in a medical use of cannabis program by a qualified patient, primary caregiver or reciprocal participant does not relieve the qualified patient, primary caregiver or reciprocal participant from:(1) criminal prosecution or civil penalties for activities not authorized in the Lynn and Erin Compassionate Use Act;(2) liability for damages or criminal prosecution arising out of the operation of a vehicle while under the influence of cannabis; or(3) criminal prosecution or civil penalty for possession or use of cannabis:(a) in the workplace of the qualified patient's, primary caregiver's or reciprocal participant's employment; or(b) at a public park, recreation center, youth center or other public place.B. A person who makes a fraudulent representation to a law enforcement officer about the person's participation in a medical use of cannabis program to avoid arrest or prosecution for a cannabis-related offense is guilty of a petty misdemeanor and shall be sentenced in accordance with the provisions of Section 31-19-1 NMSA 1978.History: Laws 2007, ch. 210, § 5; 2019, ch. 247, § 5; 2019, ch. 247, § 5; 2019, ch. 261, § 2; 2021 (1st S.S.), ch. 4, § 60. ANNOTATIONSThe 2021 (1st S.S.) amendment, effective June 29, 2021, made amendments to conform the Lynn and Erin Compassionate Use Act with the newly enacted Cannabis Regulation Act; in Subsection A, added "or reciprocal participant" after each occurrence of "primary caregiver"; and deleted former Subsection C, which related to criminal penalties for selling, distributing, dispensing or transferring cannabis.2019 Amendments. — Laws 2019, ch. 247, § 5, effective June 14, 2019, removed certain restrictions related to the use or possession of cannabis; in Subsection A, Paragraph A(3), deleted Subparagraphs A(3)(a) and A(3)(b) and redesignated former Subparagraphs A(3)(c) and A(3)(d) as Subparagraphs A(3)(a) and A(3)(b), respectively; and in Subsection C, after "If a", deleted "licensed producer" and added "licensee or the licensee's representative", and after "outside New Mexico", deleted "in violation of federal law, the licensed producer" and added "the licensee or the licensee's representative".Laws 2019, ch. 261, § 2, effective June 14, 2019, removed certain restrictions related to the use or possession of cannabis; and in Subsection A, Paragraph A(3), deleted Subparagraphs A(3)(a) and A(3)(b) and redesignated former Subparagraphs A(3)(c) and A(3)(d) as Subparagraphs A(3)(a) and A(3)(b), respectively.
NM Stat § 26-2B-6 (2021)
2021 New Mexico Statutes|Chapter 26 - Drugs and Cosmetics|Article 2B - Lynn and Erin Compassionate Use Act|Section 26-2B-6 - Advisory board created; duties.

The secretary of health shall establish an advisory board consisting of nine practitioners knowledgeable about the medical use of cannabis. The members shall be chosen for appointment by the secretary from a list proposed by the New Mexico medical society, the New Mexico nurses association, the New Mexico academy of family physicians, the New Mexico academy of physician assistants, the New Mexico pharmacists association or the New Mexico Hispanic medical association. A quorum of the advisory board shall consist of five members. The advisory board shall:A. review and recommend to the department for approval additional debilitating medical conditions that would benefit from the medical use of cannabis;B. accept and review petitions to add medical conditions, medical treatments or diseases to the list of debilitating medical conditions that qualify for the medical use of cannabis;C. convene at least twice per year to conduct public hearings and to evaluate petitions, which shall be maintained as confidential personal health information, to add medical conditions, medical treatments or diseases to the list of debilitating medical conditions that qualify for the medical use of cannabis; D. issue recommendations concerning rules to be promulgated for the issuance of the registry identification cards;E. recommend quantities of cannabis that are necessary to constitute an adequate supply for qualified patients and primary caregivers;F. recommend formulation or preparations of cannabis or cannabis products; andG. recommend quantities of cannabis that a reciprocal participant may obtain and possess. History: Laws 2007, ch. 210, § 6; 2019, ch. 247, § 6. ANNOTATIONSThe 2019 amendment, effective June 14, 2019, increased the number of members of the advisory board, provided that additional entities may propose members to be appointed to the advisory board, and required the advisory board to recommend formulation or preparations of cannabis and to recommend quantities of cannabis that a reciprocal participant may obtain and possess; in the introductory paragraph, after "consisting of", deleted "eight" and added "nine", after "practitioners", deleted "representing the fields of neurology, pain management, medical oncology, psychiatry, infectious disease, family medicine and gynecology. The practitioners shall be nationally board-certified in their area of specialty and", after "New Mexico medical society,", added "the New Mexico nurses association, the New Mexico academy of family physicians, the New Mexico academy of physician assistants, the New Mexico pharmacists association or the New Mexico Hispanic medical association", and after "shall consist of", deleted "three" and added "five"; and added new Subsections F and G.
NM Stat § 26-2B-6.1 (2021)
2021 New Mexico Statutes|Chapter 26 - Drugs and Cosmetics|Article 2B - Lynn and Erin Compassionate Use Act|Section 26-2B-6.1 - Assessment reporting.

In consultation with qualified patients and primary caregivers, the department shall produce an assessment report annually, which shall be published to the public and that includes at a minimum an evaluation of:A. the affordability of and accessibility to medical cannabis pursuant to the Lynn and Erin Compassionate Use Act; andB. the needs of qualified patients who live in rural areas, federal subsidized housing or New Mexico Indian nations, tribes or pueblos. History: Laws 2019, ch. 247, § 8; 2021 (1st S.S.), ch. 4, § 61. ANNOTATIONSThe 2021 (1st S.S.) amendment, effective June 29, 2021, made amendments to conform the Lynn and Erin Compassionate Use Act with the newly enacted Cannabis Regulation Act; in the section heading, deleted "Program regulation and administration; fees; limitations; rulemaking; licensure; issuance" and added "Assessment"; deleted former Subsections A through E; deleted subsection designation "F" and placed the language from former Subsection F as the introductory clause and redesignated former Paragraphs F(1) and F(2) as Subsections A and B, respectively; and deleted former Subsection G.Temporary provisions. — Laws 2021 (1st S.S.), ch. 4, § 70 provided:A. On June 29, 2021, all functions, personnel, money, appropriations, records, furniture, equipment and other property of the department of health's medical cannabis program that are not part of the department's medical cannabis registry powers and duties shall be transferred to the regulation and licensing department.B. On June 29, 2021, all contractual obligations and other agreements of the department of health as they pertain to the department's medical cannabis program that are not part of the department's medical cannabis registry powers and duties are binding on the regulation and licensing department.C. Statutory references to the department of health that pertain to the department's medical cannabis program that are not part of the department's medical cannabis registry powers and duties shall be deemed to be references to the cannabis control division of the regulation and licensing department.D. On June 29, 2021, any unexpended or unencumbered balance in the medical cannabis fund is transferred to the cannabis regulation fund.E. Except to the extent any administrative rules are inconsistent with the provisions of this act, any administrative rules adopted by an officer, agency or other entity whose responsibilities have been transferred pursuant to the provisions of this act to another officer, agency or other entity remain in force until amended by the officer, agency or other entity to which the responsibility for the adoption of the rules has been transferred. To the extent any administrative rules are inconsistent with the provisions of this act, such rules are null and void.
NM Stat § 26-2B-7.1 (2021)
2021 New Mexico Statutes|Chapter 26 - Drugs and Cosmetics|Article 2B - Lynn and Erin Compassionate Use Act|Section 26-2B-7.1 - Registry identification card; registration; renewal; written certification.

The department shall require a qualified patient to reapply for a registry identification card no sooner than two years and eleven months from the date the patient's current registry identification card is issued; provided that, in order to remain eligible for participation in the medical cannabis program established pursuant to the Lynn and Erin Compassionate Use Act, a qualified patient shall submit annually to the department a statement from a practitioner indicating that:A. the practitioner has examined the qualified patient during the preceding twelve months;B. the qualified patient continues to have a debilitating medical condition; andC. the practitioner believes that the potential health benefits of the medical use of cannabis would likely outweigh the health risks for the qualified patient. History: Laws 2019, ch. 247, § 9.ANNOTATIONSEffective dates. — Laws 2019, ch. 247 contained no effective date provision, but, pursuant to N.M. Const., art. IV, § 23, was effective June 14, 2019, 90 days after the adjournment of the legislature.